identified a novel GAS6/AXL regulatory pathway in the triple-negative breast cancer (TNBC) cell line, MDA-MB-231, in which GAS6 expression is upregulated by FBXO7 overexpression controlling SIX1/EYA2-mediated transcriptional activation of GAS6, and mesenchymal features of the cells (181). The gene discussed is GAS6; the disease is triple-negative breast carcinoma.